Company intelligence / Profile preview
Elfin Drugs
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
Overview
Elfin Drugs manufactures and markets a broad portfolio of generic and branded pharmaceutical products, including tablets, capsules, injections, and syrups, which are supplied both in India and to international markets. The company is WHO-GMP and ISO 9001:2008 certified with a history of providing high-quality, affordable medicines for a range of indications, including antibiotics, anti-inflammatories, antidiabetics, and more. Products are in full commercial production and distribution[2][3][6].
- Therapeutic areas
- EndocrinologyInfectious DiseasesHematologyNeurologyWomen's Health
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Elfin Drugs.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elfin Drugs.